Form 8-K - Current report:
SEC Accession No. 0001193125-16-544948
Filing Date
2016-04-18
Accepted
2016-04-18 16:31:11
Documents
5
Period of Report
2016-04-12
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d183266d8k.htm 8-K 37805
2 EX-10.1 d183266dex101.htm EX-10.1 26386
3 EX-10.2 d183266dex102.htm EX-10.2 45165
4 EX-99.1 d183266dex991.htm EX-99.1 4629
5 GRAPHIC g183266pg183266.jpg GRAPHIC 11977
  Complete submission text file 0001193125-16-544948.txt   132095
Mailing Address 3181 PORTER DRIVE PALO ALTO CA 94304
Business Address 3181 PORTER DRIVE PALO ALTO CA 94304 650-855-6777
Carbylan Therapeutics, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 161577203
SIC: 2834 Pharmaceutical Preparations